Otonomy, Inc is a biotechnology business based in the US. Otonomy shares (OTIC) are listed on the NASDAQ and all prices are listed in US Dollars. Otonomy employs 56 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Otonomy
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – OTIC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Otonomy stock price (NASDAQ: OTIC)Use our graph to track the performance of OTIC stocks over time.
Otonomy shares at a glance
|Latest market close||$2.33|
|52-week range||$1.73 - $6.98|
|50-day moving average||$2.18|
|200-day moving average||$3.07|
|Wall St. target price||$5.63|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.60|
Buy Otonomy shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Otonomy stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Otonomy price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-2.10%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
|Gross profit TTM||$-915,000|
|Return on assets TTM||-33.47%|
|Return on equity TTM||-105.11%|
|Market capitalisation||$104.2 million|
TTM: trailing 12 months
Shorting Otonomy shares
There are currently 942,968 Otonomy shares held short by investors – that's known as Otonomy's "short interest". This figure is 9.3% up from 862,380 last month.
There are a few different ways that this level of interest in shorting Otonomy shares can be evaluated.
Otonomy's "short interest ratio" (SIR)
Otonomy's "short interest ratio" (SIR) is the quantity of Otonomy shares currently shorted divided by the average quantity of Otonomy shares traded daily (recently around 311210.56105611). Otonomy's SIR currently stands at 3.03. In other words for every 100,000 Otonomy shares traded daily on the market, roughly 3030 shares are currently held short.
However Otonomy's short interest can also be evaluated against the total number of Otonomy shares, or, against the total number of tradable Otonomy shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Otonomy's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Otonomy shares in existence, roughly 20 shares are currently held short) or 0.0257% of the tradable shares (for every 100,000 tradable Otonomy shares, roughly 26 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Otonomy.
Find out more about how you can short Otonomy stock.
Otonomy share dividends
We're not expecting Otonomy to pay a dividend over the next 12 months.
Otonomy share price volatility
Over the last 12 months, Otonomy's shares have ranged in value from as little as $1.73 up to $6.983. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Otonomy's is 1.981. This would suggest that Otonomy's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Otonomy, Inc. , a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. It also develops OTIVIDEX, a sustained-exposure formulation of the steroid dexamethasone that has completed Phase III clinical trial for the treatment of Ménière's disease; OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which has completed Phase I/II clinical trial to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase I/II clinical trial for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. In addition, the company develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc.
Stocks similar to Otonomy
Otonomy in the news
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Frequently asked questionsWhat percentage of Otonomy is owned by insiders or institutions?
Currently 1.016% of Otonomy shares are held by insiders and 70.148% by institutions. How many people work for Otonomy?
Latest data suggests 56 work at Otonomy. When does the fiscal year end for Otonomy?
Otonomy's fiscal year ends in December. Where is Otonomy based?
Otonomy's address is: 4796 Executive Drive, San Diego, CA, United States, 92121 What is Otonomy's ISIN number?
Otonomy's international securities identification number is: US68906L1052 What is Otonomy's CUSIP number?
Otonomy's Committee on Uniform Securities Identification Procedures number is: 68906L105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert